|Donner Trail students gain medical knowledge at Tahoe Forest Hospital|
Laurel Holmer, Tahoe Forest's Infection Control Practitioner, led students through two exercises assisted by teachers and parents. They performed a ... They also learned about identifying gram-positive versus gram-negative bacteria using a microscope.
Sierra Sun - Fri, 27 Nov 2015 09:26
|Increased cytotoxicity and streptolysin O activity in group G streptococcal ...|
Gram-staining detected massive bacterial load in the biopsies with Gram-positive chains, aggregations as well as single cocci found in all analyzed tissues (Fig. 5A). The gene expression of slo and sagA (SLS) in the day 0 tissue biopsies were ...
Nature.com - Wed, 25 Nov 2015 01:38
|Arsanis Initiates Phase 1 Study of Lead Product Candidate ASN100|
... most important Gram-positive and Gram-negative bacterial pathogens threatening hospitalized and high-risk patients, with its lead therapeutic candidate, ASN100, aimed at the prevention and treatment of serious S. aureus infections in clinical ...
PR Newswire (press release) - Mon, 23 Nov 2015 06:37
|Mechanistic analysis of a synthetic inhibitor of the Pseudomonas aeruginosa ...|
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen responsible for many human infections. LasI is an acyl-homoserine lactone synthase that produces a quorum-sensing (QS) signal that positively ... and Trp33 and a wide cleft that ...
Nature.com - Mon, 23 Nov 2015 02:52
|Motif Bio Plc Dr. Graham G Lumsden Phase III Clinical Trials|
Iclaprim is being developed for the treatment of the most common and serious bacterial infections such as acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP), including those caused by resistant ...
DirectorsTalk Interviews - Wed, 25 Nov 2015 00:44
|Tetraphase Pharmaceuticals, Inc. Short Interest Update|
... multi-drug resistant Gram-negative infections. . The Companys frequently used products, such as Zyvox and Cubicin, are limited to Gram-positive bacteria and thus are rarely used as a first-line empiric monotherapy if broad bacterial coverage is ...
Money Flow Index - Wed, 25 Nov 2015 07:33
|Combating Drug-Resistant Bacteria with Innovative Therapeutics|
'Superbugs' that cause drug-resistant infections are eliminating the effectiveness of standard antibiotics, occurring when a microorganism (bacteria, fungus, virus or parasite) is no longer sensitive to a drug's inhibitory or killing mechanisms. “This ...
SelectScience.net (press release) (registration) - Mon, 23 Nov 2015 01:56
|Will Tetraphase Pharmaceuticals Incorporated (NASDAQ:TTPH) beat previous EPS ...|
The Company's frequently used products, such as Zyvox and Cubicin, are limited to Gram-positive bacteria and thus are rarely used as a first-line empiric monotherapy if broad bacterial coverage is required. During the year ended December 31, 2012 ...
The Bulletin - Sat, 28 Nov 2015 00:15